Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial-Reference-Cited by-同舟云学术

Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial

Published:2009-07 Issue:7 Volume:7 Page:735-748
ISSN:1477-9072
Container-title:Expert Review of Cardiovascular Therapy
language:en
Short-container-title:Expert Review of Cardiovascular Therapy

Author:

Marchioli Roberto,Levantesi Giacomo,Silletta Maria G,Barlera Simona,Bernardinangeli Marino,Carbonieri Emanuele,Cosmi Francesco,Franzosi Maria G,Latini Roberto,Lucci Donata,Maggioni Aldo Pietro,Moretti Luciano,Nicolosi Gian L,Porcu Maurizio,Rossi Maria G,Tognoni Gianni,Tavazzi Luigi

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/erc.09.70

Reference71 articles.

1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

2. Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death

3. Prevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs

4. Fish Consumption, n-3 Fatty Acids in Cell Membranes, and Heart Rate Variability in Survivors of Myocardial Infarction With Left Ventricular Dysfunction

5. Autonomic Tone as a Cardiovascular Risk Factor: The Dangers of Chronic Fight or Flight

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are the ratio and amount of n-6 and n-3 fatty acids associated with cardiovascular outcomes?—a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials;Food Bioscience;2024-06

2. Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC);European Journal of Preventive Cardiology;2022-02-01

3. Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial;Clinical Research in Cardiology;2021-08-28

4. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials;Pharmacological Research;2020-10

5. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease;Cochrane Database of Systematic Reviews;2020-02-29